Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation

Thrombosis is a frequent cause of cardiovascular mortality and hospitalization. Current antithrombotic strategies, however, target both thrombosis and physiological hemostasis and thereby increase bleeding risk. In recent years the pathophysiological understanding of thrombus formation has significa...

Full description

Bibliographic Details
Main Authors: Qing Zhang, Qurrat Ul Ain, Christian Schulz, Joachim Pircher
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151926/full
_version_ 1797851710710874112
author Qing Zhang
Qing Zhang
Qurrat Ul Ain
Christian Schulz
Christian Schulz
Joachim Pircher
Joachim Pircher
author_facet Qing Zhang
Qing Zhang
Qurrat Ul Ain
Christian Schulz
Christian Schulz
Joachim Pircher
Joachim Pircher
author_sort Qing Zhang
collection DOAJ
description Thrombosis is a frequent cause of cardiovascular mortality and hospitalization. Current antithrombotic strategies, however, target both thrombosis and physiological hemostasis and thereby increase bleeding risk. In recent years the pathophysiological understanding of thrombus formation has significantly advanced and inflammation has become a crucial element. Neutrophils as most frequent immune cells in the blood and their released mediators play a key role herein. Neutrophil-derived cathelicidin next to its strong antimicrobial properties has also shown to modulates thrombosis and thus presents a potential therapeutic target. In this article we review direct and indirect (immune- and endothelial cell-mediated) effects of cathelicidin on platelets and the coagulation system. Further we discuss its implications for large vessel thrombosis and consecutive thromboinflammation as well as immunothrombosis in sepsis and COVID-19 and give an outlook for potential therapeutic prospects.
first_indexed 2024-04-09T19:21:06Z
format Article
id doaj.art-53ff38cb42b744bab3d6b7bc795dd89d
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-09T19:21:06Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-53ff38cb42b744bab3d6b7bc795dd89d2023-04-05T10:15:30ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-04-011410.3389/fimmu.2023.11519261151926Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammationQing Zhang0Qing Zhang1Qurrat Ul Ain2Christian Schulz3Christian Schulz4Joachim Pircher5Joachim Pircher6Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians- Universität, Munich, GermanyPartner Site Munich Heart Alliance, DZHK (German Centre for Cardiovascular Research), Munich, GermanyMedizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians- Universität, Munich, GermanyMedizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians- Universität, Munich, GermanyPartner Site Munich Heart Alliance, DZHK (German Centre for Cardiovascular Research), Munich, GermanyMedizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians- Universität, Munich, GermanyPartner Site Munich Heart Alliance, DZHK (German Centre for Cardiovascular Research), Munich, GermanyThrombosis is a frequent cause of cardiovascular mortality and hospitalization. Current antithrombotic strategies, however, target both thrombosis and physiological hemostasis and thereby increase bleeding risk. In recent years the pathophysiological understanding of thrombus formation has significantly advanced and inflammation has become a crucial element. Neutrophils as most frequent immune cells in the blood and their released mediators play a key role herein. Neutrophil-derived cathelicidin next to its strong antimicrobial properties has also shown to modulates thrombosis and thus presents a potential therapeutic target. In this article we review direct and indirect (immune- and endothelial cell-mediated) effects of cathelicidin on platelets and the coagulation system. Further we discuss its implications for large vessel thrombosis and consecutive thromboinflammation as well as immunothrombosis in sepsis and COVID-19 and give an outlook for potential therapeutic prospects.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151926/fullthrombosisimmunothrombosiscathelicidin (LL-37)plateletsthromboinflammationLL-37
spellingShingle Qing Zhang
Qing Zhang
Qurrat Ul Ain
Christian Schulz
Christian Schulz
Joachim Pircher
Joachim Pircher
Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation
Frontiers in Immunology
thrombosis
immunothrombosis
cathelicidin (LL-37)
platelets
thromboinflammation
LL-37
title Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation
title_full Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation
title_fullStr Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation
title_full_unstemmed Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation
title_short Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation
title_sort role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation
topic thrombosis
immunothrombosis
cathelicidin (LL-37)
platelets
thromboinflammation
LL-37
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151926/full
work_keys_str_mv AT qingzhang roleofantimicrobialpeptidecathelicidininthrombosisandthromboinflammation
AT qingzhang roleofantimicrobialpeptidecathelicidininthrombosisandthromboinflammation
AT qurratulain roleofantimicrobialpeptidecathelicidininthrombosisandthromboinflammation
AT christianschulz roleofantimicrobialpeptidecathelicidininthrombosisandthromboinflammation
AT christianschulz roleofantimicrobialpeptidecathelicidininthrombosisandthromboinflammation
AT joachimpircher roleofantimicrobialpeptidecathelicidininthrombosisandthromboinflammation
AT joachimpircher roleofantimicrobialpeptidecathelicidininthrombosisandthromboinflammation